Accelerating freeze drying cycle development with just seven vials
Compared with other small-scale R&D freeze dryers, the LyoCapsule lyophilizer is the only system that can monitor and independently control the wall temperature via use of the center vial product temperature.
SP Scientific announces the LyoCapsuleFreeze Dryer - an exciting new lyophilization instrument that delivers results comparable to larger R&D freeze dryers enabling a Quality by Design (QbD) approach to cycle development even when materials are highly expensive or limited in quantity. This addition aligns with SP’s mission to provide ‘line of sight’ scale-up equipment and technology from R&D through to commercial freeze drying.
The LyoCapsule freeze dryer's small chamber incorporates a unique cylindrical inner chamber, or ‘capsule,’ to hold the vials and utilizes wall temperature control to ensure that edge vials dry under the same process conditions as center vial. Employing this technology, this mini freeze dryer can be used to mimic the performance of a larger development freeze dryer, utilizing small quantities of costly materials, such as developmental biological drugs and requires far less material preparation time, while still facilitating robust and cost-effective cycle development.
The LyoCapsule freeze dryer may be used to reliably screen formulations for freeze drying feasibility, optimize the freeze drying cycle during development, evaluate efficient process scale-up and much more without requiring the use of large quantities of materials and undue sample preparation time. The unit can accommodate 2 mL to 20 mL vials; seven 20 mL vials can fit comfortably on the circular shelf.
Compared with other small-scale R&D freeze dryers, SP’s LyoCapsule lyophilizer is the only system that can monitor and independently control the wall temperature via use of the center vial product temperature. Utilizing the center vial product temperature enables better control and replication of center vial drying behavior during cycle development. Additionally, vials in the LyoCapsule freeze dryer are in direct contact with the shelf surface replicating the same conditions that are found in larger freeze dryers. A full suite of Process Analytical Technologies (PAT) tools further complements SP Scientific’s ‘line of sight’ scale up as the technologies are available at all freeze dryer scales including production.
In addition, the LyoCapsule freeze dryer offers the user robust process monitoring tools including chamber and condenser capacitance manometers, Pirani gauge, product thermocouples, SMART Freeze Drying technology and TDLAS as an add-on option.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance